 |
- The
current portfolio of DESMA PHARMA Group is the
result of acquisition of brands from local and
multinational companies.
Pharmaceutical
groups decide to divest their products for several
reasons such as the launch of new key products,
the change of strategic plans, portfolio optimization
or mergers.
- At
these stages, DESMA PHARMA Group becomes a preferential
partner as we offer a flexible and integrated
approach and a well-proven expertise and know-how
in dealing product´s
acquisition.
|
 |
-
We
are permanently focused on the acquisition of
well-established pharmaceutical products, individual
brands or complete portfolios, as well as in
the purchase of whole companies.
- Additionally,
our two pharmaceutical facilities provide an
internal solution to the manufacturing needs
of most of the products acquired.
If
you are considering divesting a brand, with or
without selling the company, please do not hesitate
to contact us.
|
|
|
|
